Nasdaq · Healthcare

BIOHARVEST SCIENCES INC. (BHST)

As-reported financials and recent SEC filings for BIOHARVEST SCIENCES INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$34.5M

Net income

$-11.1M

Net margin

-32.3%

Diluted EPS

—

ROE

-43.8%

P/E (TTM)

—

Market cap

—

Debt / equity

—

Income statement (as reported)

Line	FY2025	FY2024	FY2024
Revenue	$34.5M	$25.2M	$12.7M
Gross profit	$20.5M	$13.9M	$5.6M
Operating income	$-5.6M	$-7.0M	$-10.0M
Net income	$-11.1M	$-12.9M	$-12.6M
Diluted EPS	—	—	—

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

6-K2026-06-18

6-K2026-05-28

6-K2026-05-14

6-K2026-05-14

6-K2026-05-14

6-K2026-05-13

6-K2026-05-12

6-K2026-05-11

Largest Healthcare peers

UNH

UNITEDHEALTH GROUP INC

All Healthcare companies →

Go deeper on BHST

Search BIOHARVEST SCIENCES INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.